about
sameAs
Emergence of Congenital Zika Syndrome: Viewpoint From the Front LinesZika Virus Infection and Stillbirths: A Case of Hydrops Fetalis, Hydranencephaly and Fetal DemiseTransient Hearing Loss in Adults Associated with Zika Virus InfectionTrends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemicRecurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico.An integrated map of HIV genome-wide variation from a population perspective.DETC induces Leishmania parasite killing in human in vitro and murine in vivo models: a promising therapeutic alternative in Leishmaniasis.SOD1 plasma level as a biomarker for therapeutic failure in cutaneous leishmaniasis.Ascorbic acid has superior ex vivo antiproliferative, cell death-inducing and immunomodulatory effects over IFN-α in HTLV-1-associated myelopathyA new ensemble coevolution system for detecting HIV-1 protein coevolution.CRF19_cpx is an Evolutionary fit HIV-1 Variant Strongly Associated With Rapid Progression to AIDS in Cuba.Circulating Biomarkers of Immune Activation, Oxidative Stress and Inflammation Characterize Severe Canine Visceral Leishmaniasis.DETC-based bacterial cellulose bio-curatives for topical treatment of cutaneous leishmaniasis.CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis.IFN-β induces greater antiproliferative and proapoptotic effects and increased p53 signaling compared with IFN-α in PBMCs of Adult T-cell Leukemia/Lymphoma patientsA Fashi Lymphoproliferative Phenotype Reveals Non-Apoptotic Fas Signaling in HTLV-1-Associated NeuroinflammationAnalyses of HTLV-1 sequences suggest interaction between ORF-I mutations and HAM/TSP outcome.Differential Expression of the Eicosanoid Pathway in Patients With Localized or Mucosal Cutaneous Leishmaniasis.Heme impairs prostaglandin E2 and TGF-beta production by human mononuclear cells via Cu/Zn superoxide dismutase: insight into the pathogenesis of severe malaria.Glaucoma and Congenital Zika Syndrome.Pathogen transcriptional profile in nasopharyngeal aspirates of children with acute respiratory tract infection.Simultaneous RNA quantification of human and retroviral genomes reveals intact interferon signaling in HTLV-1-infected CD4+ T cell lines.Systems Approach Reveals Nuclear Factor Erythroid 2-Related Factor 2/Protein Kinase R Crosstalk in Human Cutaneous Leishmaniasis.Proteome profiling of human cutaneous leishmaniasis lesion.IFN-beta impairs superoxide-dependent parasite killing in human macrophages: evidence for a deleterious role of SOD1 in cutaneous leishmaniasis.A Bayesian network approach to study host and viral genetic correlates of HIV-1 disease progression.Monocyte accumulation is an early event in HAM/TSP pathogenesis, while monocyte activation and IFN-regulated gene expression persist in chronic HAM/TSP.CD64 as a biomarker and therapeutic target in HAM/TSP and HTLV-1-associated Infective Dermatitis.ORFI genetic polymorphisms in geographically distinct HTLV-1 infections.A genetic IFN/STAT1/FAS axis determines CD4 T stem cell memory levels and apoptosis in healthy controls and Adult T-cell Leukemia patients.B cell costimulatory molecules as potential biomarkers in HAM/TSP.A selective defect in Fas-mediated apoptosis in HAM/TSP: An ex vivo, in vitro and in silico study.Superior antiviral and antiproliferative activity of IFN-beta vs. IFN-alpha in primary ATL cells occurs downstream of STAT1 signaling.Ascorbic acid has superior antiviral and antiproliferative effects over IFN-alpha in HAM/TSP PBMC ex vivo.Decreased RORC expression and downstream signaling in HTLV-1-associated Adult T-cell Lymphoma/Leukemia uncovers an antiproliferative IL17 link: a potential target for immunotherapy?ID: 239Virus genetic variability involvement in transmissibility of HIV-1 immune activation and disease progression267Neutrophils and Macrophages Cooperate in Host Resistance against Leishmania braziliensis InfectionIFN-beta pro-apoptotic and antiproliferative activity is superior to IFN-alpha in adult T-cell leukemia: Ex vivo response predicts survival
P50
Q24261097-03E13AD6-5F97-418F-A6D5-AC47A750C39AQ24261185-34FA1E32-6A9A-4AA2-B0F6-58A1E682DA96Q27980443-54E45AC2-F250-4AC3-8797-131EBB37513AQ28540490-291EF7EA-2DB8-4B55-BC22-E6E6858B9433Q30145646-6008FE91-BCC6-4886-B4DC-51F2933AA4C9Q30373040-E8AA1246-E3C3-49B2-820D-CF62114DE338Q33784195-5BF2822E-3B01-4094-81BF-473547F53BCEQ33816072-E489B9EA-7A67-451E-BDF2-80D6B0BBA827Q34359754-F83D1653-A9C2-4343-A1A0-4CE4CC04C4DAQ35094794-C863D1E9-DB86-4AB8-9764-6FF564133CE9Q35795095-E92277BE-A0D0-4862-80EB-2BF8AAFB3244Q37232628-BB681356-2380-4CC6-8D4F-86D3F903E8BDQ37475900-67668E73-3F11-4284-9E59-A3FCB25A2172Q37579811-5CDABD67-C6B9-4B59-9060-3A22651E8140Q37634752-B20BA206-559B-42DA-BDB5-EAC8A29BA8DDQ37639788-E9EF8A32-2948-47CF-8121-2AA381D789F8Q38894410-97DF74F6-832D-4F37-B8F2-7C467DA4C43BQ38941290-9F351764-B571-4FBE-A95C-405436343A25Q39862156-1DF06FC6-2727-44E6-9F20-40DD8C0213F1Q40052055-100C051A-8655-4B34-A2C7-5CD77084D756Q41090825-F51C5989-DED2-41E0-BE5D-83DAAD1F6FE6Q41381866-A262FA82-FB57-4451-BB8E-E8757CE36F56Q41673013-032298DE-517E-4C92-8D5B-9D4CD5501E24Q41744907-C8AECCDD-0A5C-48A4-84F9-31B95F17F7ECQ44823542-3ECC627C-9063-472D-97CF-8D1C35982B6DQ46037124-D8B11395-C163-41FC-9852-29D660A699A8Q54662284-2B35F2C1-08AB-4E4B-823F-015BD8EA0023Q55068462-FA962E5E-DFE4-4267-9DD5-B401BEDF43F6Q55076214-8D0BC6B1-016E-42E1-A377-F70CF35C06BEQ55231926-A0A45EBB-A58C-44C0-B75A-F6E461CC9F9DQ55344881-DED06B9F-0891-429E-A198-F596A0928EF8Q55532880-D186843D-4447-43B6-AC0E-81DB6916C47EQ55543887-5A71B2EF-CA16-435D-A025-1D1C2DA2896BQ55657523-6C3C5CE9-6856-4E2E-BF04-C87531B1D980Q56451260-E873D278-B0AA-4CEC-9F15-1B0962AFF8C5Q56451316-EB1439E9-6887-407A-88E9-BCC29A56947CQ56451330-12986BC6-F6FD-4E3A-A0E0-1833D10A3F0CQ56451345-1984CDB5-D0FF-46AA-94DD-79CC553334F5Q56451377-DD45133F-B8AF-4E56-BBD1-E2441B19866EQ56451379-7948D903-8887-43C5-9A9E-0B5B85883EB5
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ricardo Khouri
@ast
Ricardo Khouri
@en
Ricardo Khouri
@es
Ricardo Khouri
@nl
Ricardo Khouri
@pt
Ricardo Khouri
@sl
type
label
Ricardo Khouri
@ast
Ricardo Khouri
@en
Ricardo Khouri
@es
Ricardo Khouri
@nl
Ricardo Khouri
@pt
Ricardo Khouri
@sl
prefLabel
Ricardo Khouri
@ast
Ricardo Khouri
@en
Ricardo Khouri
@es
Ricardo Khouri
@nl
Ricardo Khouri
@pt
Ricardo Khouri
@sl
P1053
M-3184-2018
P106
P1153
26221302500
P21
P31
P3829
P496
0000-0001-5664-4436